The current SONN market cap is 5.22M. The company's latest EPS is USD -6.1355 and P/E is -0.28.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 37k | 37k | 37k | 37k | 19k |
Operating Income | -5.61M | -5.66M | -3.92M | -3.6M | -1.28M |
Net Income | -5.54M | -5.67M | -3.95M | -3.68M | -1.17M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 30.14M | 0 | 484k | 350k | 148k |
Operating Income | -8.57M | -24.24M | -25.09M | -29.67M | -18.79M |
Net Income | -17.84M | -65.6M | -24.98M | -29.72M | -18.83M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 4.94M | 13.31M | 10.04M | 5.43M | 5.34M |
Total Liabilities | 8.48M | 7.94M | 6.62M | 5.66M | 2.77M |
Total Equity | -3.54M | 5.37M | 3.42M | -226k | 2.57M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 31.53M | 7.99M | 28.99M | 5.83M | 5.43M |
Total Liabilities | 34.69M | 4.97M | 6.73M | 8.37M | 5.66M |
Total Equity | -3.15M | 3.02M | 22.26M | -2.54M | -226k |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.92M | -10.61M | -16.78M | -21.34M | -3.09M |
Investing | N/A | -261k | -273k | -443k | N/A |
Financing | 4.56M | 19.21M | 21.02M | 21.01M | 3.84M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.05M | -15.62M | -22.55M | -27.69M | -21.34M |
Investing | 679k | -76k | -4k | -896k | -443k |
Financing | 3.34M | 23.01M | 42.83M | 4.01M | 21.01M |
Market Cap | 5.22M |
Price to Earnings Ratio | -0.28 |
Price to Sales Ratio | 35.27 |
Price to Cash Ratio | 2.29 |
Price to Book Ratio | -23.09 |
Dividend Yield | - |
Shares Outstanding | 3.07M |
Average Volume (1 week) | 9.05k |
Average Volume (1 Month) | 14.95k |
52 Week Change | -67.80% |
52 Week High | 26.40 |
52 Week Low | 1.08 |
Spread (Intraday) | 0.1 (5.71%) |
Company Name | Sonnet BioTherapeutics Holdings Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.sonnetbio.com |
Industry | management consulting svcs (8742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.